Advertisement

Risk Factors, Course, and Prognosis of Multiple Selerosis

  • J. F. Kurtzke

Abstract

It has been said that to know multiple sclerosis (MS) is to know Neurology — and vice versa. In the occident this is among young adults the most common disease with primary pathologic changes in the central nervous system. It has been characterized as a disease of unknown cause, inadequate treatment, and unpredictable course. It has also been the single neurologic disorder about which the most has been written, and in this regard epidemiology has contributed its share. There is then some information available for this disease as to risk factors, the course of the illness, and factors predictive of this course.

Keywords

Multiple Sclerosis Multiple Sclerosis Patient Annual Incidence Rate Faroe Island Multiple Sclerosis Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fox JP, Hall CE, Elveback LR (1970) Epidemiology. Man and disease. Macmillan, London, pp 185,339Google Scholar
  2. 2.
    Kurtzke JF (1983) Epidemiology and risk factors in thrombotic brain infarction. In: Harrison MJG, Dyken ML (eds) Cerebral vascular disease. Butterworths, London, pp 27–45Google Scholar
  3. 3.
    Charcot J-M (1877) Leçons sur les Maladies du Système Nerveux faites a la Salpétrière [Recuillies et Publiées par Bourneville], vol I, 3rd edn. Adrien Delahaye, Paris, 1190Google Scholar
  4. 4.
    Moxon W (1873) Case of insular sclerosis of brain and spinal cord. Lancet i: 236Google Scholar
  5. 5.
    Goldberg ID, Kurland LT (1962) Mortality in 33 countries from diseases of the nervous system. World Neurol 3:444–465PubMedGoogle Scholar
  6. 6.
    Massey EW, Schoenberg BS (1982) International patterns of mortality from multiple sclerosis. Neuroepidemiology 1:189–196CrossRefGoogle Scholar
  7. 7.
    Kurtzke JF, Kurland LT, Goldberg ID, Choi NW (1973) Multiple sclerosis. In: Kurland LT, Kurtzke JF, Goldberg ID Epidemiology of neurologic and sense organ disorders. Harvard University Press, Cambridge, pp 64–107Google Scholar
  8. 8.
    Kurtzke JF (1983) Epidemiology of multiple sclerosis. In: Hallpike JF, Adams CWM, Tour-tellotte WW (eds) Multiple sclerosis. Pathology, diagnosis and management. Chapman and Hall, London, pp47–95Google Scholar
  9. 9.
    Kurtzke JF (1985) Epidemiology of multiple sclerosis. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical Neurology, revised series, vol. 3: demyelinating diseases. Elsevier Science, Amsterdam, pp 259–287Google Scholar
  10. 10.
    Kurtzke JF (1975) A reassessment of the distribution of multiple sclerosis, part one, part two. Acta Neurol Scand 51:110–136, 137-157PubMedCrossRefGoogle Scholar
  11. 11.
    Kurtzke JF (1980) The geographic distribution of multiple sclerosis: an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 62:65–80PubMedCrossRefGoogle Scholar
  12. 12.
    Dean D, Grimaldi G, Kelly R, Karhausen L (1979) Multiple sclerosis in southern Europe. I. Prevalence in Sicily in 1975. J Epidemiol Commun Hlth 33:107–110CrossRefGoogle Scholar
  13. 13.
    Granieri G, Rosati G (1982) Italy — a medium-or high-risk area for multiple sclerosis? An epidemiologic study in Barbagia, Sardinia, southern Italy. Neurology 32:466–472PubMedGoogle Scholar
  14. 14.
    Kurtzke JF, Beebe GW, Norman JE Jr (1979) Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 29:1228–1235PubMedGoogle Scholar
  15. 15.
    Kurtzke JF (1978) Data registries on selected segments of the population: veterans. Adv Neurol 19:55–67PubMedGoogle Scholar
  16. 16.
    Kurtzke JF, Beebe GW, Norman JE Jr (1985) Epidemiology of multiple sclerosis in U.S. veterans: III. Migration and the risk of MS. Neurology 35:672–678Google Scholar
  17. 17.
    Beebe GW, Kurtzke JF, Kurland LT, Auth TL, Nagler E (1967) Studies on the natural history of multiple sclerosis: 3. Epidemiologic analysis of the Army experience in World War II. Neurology 17:1–17Google Scholar
  18. 18.
    Kurtzke JF, Hyllested E (1986) Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission and the nature of MS. Neurology 36:307–328Google Scholar
  19. 19.
    Kurtzke JF, Hyllested A (1987) Multiple sclerosis in the Faroe Islands. III. An alternative assessment of the three epidemics. Acta Neurol Scand (in press)Google Scholar
  20. 20.
    Kurtzke JF, Gudmundsson KR, Bergmann S (1982) Multiple sclerosis in Iceland: 1. Evidence of a postwar epidemic. Neurology 32:143–150PubMedGoogle Scholar
  21. 21.
    Hyllested E (1956) Disseminated sclerosis in Denmark: prevalence and geographical distribution. Jørgensen, CopenhagenGoogle Scholar
  22. 22.
    Kurtzke JF (1968) Multiple sclerosis and infection from an epidemiologic aspect. Neurology 18 (part 2): 170–175PubMedGoogle Scholar
  23. 23.
    Detels R, Visscher BR, Malmgren RM, Coulson AH, Lucia MV, Dudley JP (1977) Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol 105:303–310PubMedGoogle Scholar
  24. 24.
    Alter M, Okihiro M, Rowley W, Morris E (1971) Multiple sclerosis among Orientals and Caucasians in Hawaii. Neurology 21:122–130PubMedGoogle Scholar
  25. 25.
    Bobowick AR, Kurtzke JF, Brody JA, Hrubec Z, Gillespie M (1978) Twin study of multiple sclerosis: an epidemiologic inquiry. Neurology 28:978–987PubMedGoogle Scholar
  26. 26.
    Heltberg A, Holm NV (1982) Concordance in twins and recurrence in sibships in multiple sclerosis. Lancet 1:1068Google Scholar
  27. 27.
    Ebers GC, Bulman DE, Sadovnick AD et al (1986) A population-based study of multiple sclerosis in twins. J Engl J Med 315:1638–1642CrossRefGoogle Scholar
  28. 28.
    Kurtzke JF (1985) Neurological system. In: Holland WW, Detels R, Knox G (eds) Oxford textbook of public health, vol 4. Specific applications. Oxford University Press, pp 203–249Google Scholar
  29. 29.
    Roberts DF, Roberts MJ, Poskanzer DC (1979) Genetic analysis of multiple sclerosis in Orkney. J Epidemiol Comm Hlth 33:229–235CrossRefGoogle Scholar
  30. 30.
    Krantz JS (1983) Multiple sclerosis case-control study in Olmsted and Mower Counties, Minnesota. PhD thesis, University of MinnesotaGoogle Scholar
  31. 31.
    Norman JE Jr, Kurtzke JF, Beebe GW (1983) Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis. J Chron Dis 36:551–559PubMedCrossRefGoogle Scholar
  32. 32.
    Percy AK, Nobrega FT, Okazaki H, Glattre E, Kurland LT (1971) Multiple sclerosis in Rochester, Minnesota — a 60-year appraisal. Arch Neurol 25:105–111PubMedGoogle Scholar
  33. 33.
    Kurtzke JF, Beebe GW, Nagler B, Nefzger MD, Auth TL, Kurland LT (1970) Studies on the natural history of multiple sclerosis: V. Long-term survival in young men. Arch Neurol 22:215–225PubMedGoogle Scholar
  34. 34.
    Kurtzke JF (1970) Clinical manifestations of multiple sclerosis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical Neurology, vol 9. Multiple sclerosis and other demyelinating diseases. North-Holland, Amsterdam, pp 161–216Google Scholar
  35. 35.
    Kurtzke JF (1972) Multiple sclerosis death rates from underlying cause and total deaths. Acta Neurol Scand 48:148–162PubMedCrossRefGoogle Scholar
  36. 36.
    Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL (1977) Studies on the natural history of multiple sclerosis — 8. Early prognostic features of the later course of illness. J Chron Dis 30: 819–830PubMedCrossRefGoogle Scholar
  37. 37.
    Kurtzke JF (1961) On the evaluation of disability in multiple sclerosis. Neurology 11:686–694PubMedGoogle Scholar
  38. 38.
    Kurtzke JF (1984) Disabililty rating scales in multiple sclerosis. Ann NY Acad Sci 436:347–360PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. F. Kurtzke
    • 1
  1. 1.Neurology Service and Neuroepidemiology Research Program, Veterans Administration Medical Center and Departments of Neurology and Community and Family MedicineGeorgetown University Medical SchoolUSA

Personalised recommendations